Showing posts with label clinical implication. Show all posts
Showing posts with label clinical implication. Show all posts

Monday, 8 April 2013

AMNIOTIC FLUID SHAKE TEST


AMNIOTIC FLUID SHAKE TEST
The shake test is a qualitative measurement of the amount of pulmonary surfactant contained in the amniotic fluid. It is quick and inexpensive. It is a bedside test of lung maturity. In an obstetric emergency, an immediate decision about delivery can be made. The advantages of this test over the others are that a physician, technician or must can perform it and the test are highly reliable as
¨     It evaluates the ability of pulmonary surfactant to generate a stable foam in the presence of ethanol.
¨     Ethanol, a nonfoaming competitive surfactant, eliminates the contributions of protein, bile salts and salts of free fatty acids to the formation of a stable foam.
¨     At an ethanol concentration of 47.5 percent, stable bubbles that foam after shaking are due to amniotic fluid lecithin.
¨     Positive tests, a complete ring of bubbles at the meniscus with a 1:2 dilution of amniotic fluid, are rarely associated with neonatal RDS.
¨     It is a screening test that gives useful information if mature.
Reference Values
Normal
Positive: persistence of a foam ring for 15 minutes after shaking (at an amniotic fluid – alcohol dilution of 1:2) indicates lung maturity.
Procedure:
1.     Test is based on the ability of amniotic fluid surfactant to form a complete ring of bubbles on the surface of the amniotic fluid in the presence of 95% ethanol.
2.     Place a mixture of 95% ethanol and amniotic fluid in an appropriate container and shake for 15 seconds. A commercial kit is also available.
Clinical implications:
1.     If a complete ring of foam forms and persists for 15 minutes the test is positive.
2.     If no ring of bubbles forms, the test is negative.
3.     The test has a high false – negative rate but a low false – positive rate. The L/S ratio must be >4:1 for this test to be positive.
Interfering Factors
1.     Blood or meconium contamination can alter results.
2.     Contamination of glassware or reagents can alter test results.
Interventions
Pretest patient care
1.     Obtain informed consent.
2.     Explain the procedure and the reason foe testing.
3.     Use sterile techniques.
Posttest patient care
1.     Interpret test outcome counsel appropriately.
2.     Provide counseling if test is negative.
3.     Provide future treatment modalities.